Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NMT opts for new business model after deal with Roche

This article was originally published in Clinica

Executive Summary

UK retractable device specialist NMT group had high hopes for sales of its technology into the US market last year, but slow implementation of the US Needlestick Safety and Prevention Act by hospitals resulted in budgeted sales failing to materialise. Indeed, the US provided another disappointment for the Livingston, Scotland company when it decided to withdraw its US direct sales force.

Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT061561

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel